FDA Approved: BESREMI — Original Application (PharmaEssentia USA)

View source ↗

Summary

The FDA approved Besremi (ropeginterferon alfa-2b-nnqv) from PharmaEssentia USA for adults with polycythemia vera who require treatment, under an original appli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycythemia Vera

Drugs mentioned

• BESREMI (ropeginterferon alfa-2b)

Snippet

ORIG AP for BESREMI (ROPEGINTERFERON ALFA-2B)